Rigel Pharmaceuticals Inc
RIGL· Nasdaq
RIGLRigel Pharmaceuticals Inc
Released Aug 5, 2014, during market hours
10-Q filed Aug 5, 2014, 36 days after period end · 0001104659-14-056803
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Net Income | — | — | — | -$21.47M |
| EPS Diluted | -$0.29 | -$0.26 | -$0.35 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2014 · filed Aug 5, 2014 · 36 d after period end
6.2% from the close of Aug 4, 2014 to the close of Aug 5, 2014, the first after the release.
